Microscopic polyangiitis in a patient with primary biliary cirrhosis: Treatment complications.

1. Khan TA, Cuchacovich R, Espinoza LR, Lata S, Patel NJ, García-Valladares I, et al. Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use. Semin Arthritis Rheum. 2011;41:445–54. 2. Espinoza LR, Pérez Alamino R. Cocaine-induced vasculitis: Clinical and immunological spectrum. Curr Rheumatol Rep. 2012;14:532–8. 3. Gross RL, Brucker J, Bahce-Altuntas A, Abadi MA, Lipoff J, Kotlyar D, et al. A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clin Rheumatol. 2011;30:1385–92. 4. Ventura Vilamala M, Caudevilla Gáligo F, Vidal Giné C, Grupo de Investigadores SELECTO. Cocaína adulterada con Levamisol: posibles implicaciones clínicas. Med Clin (Barc). 2011;136:365–8. 5. Álvarez Díaz H, Mariño Callejo AI, García Rodríguez JF, Rodríguez Pazos L, Gómez Buela I, Bermejo Barrera AM. ANCA-positive vasculitis induced by levamisole-adulterated cocaine and nephrotic syndrome: The kidney as an unusual target. Am J Case Rep. 2013;14:557–61. 6. Graf J. Rheumatic manifestations of cocaine use. Curr Opin Rheumatol. 2013;25:50–5. 7. McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol. 2011;6:2799–805. 8. Carlson AQ, Tuot DS, Jen KY, Butcher B, Graf J, Sam R, et al. Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: A series of 4 cases. Medicine (Baltimore). 2014;93:290–7. 9. Gulati S, Donato AA. Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: A case report and review of the literature. J Thromb Thrombolysis. 2012;34:7–10.